Skip to main content
Find more clinical trials

Near Infrared Light Stimulation for Early to Mid-Stage Dementia

Start: October 15, 2018
End: October 15, 2020
Enrollment: 100

What Is This Study About?

This study will evaluate the effects of repeated brief exposure to near infrared light stimulation in people with early- to mid-stage Alzheimer's disease who have problems with attention span, working memory, learning and remembering, planning, organizing, self-monitoring, inhibition, and flexible thinking.

Do I Qualify To Participate in This Study?

Minimum Age: 50 Years

Maximum Age: 85 Years

Must have:

  • Diagnosis of dementia, probable Alzheimer's type
  • Dementia symptoms not greater than early to mid-stage dementia
  • Generally healthy as indicated by recent physical examination within past 6 months
  • If labs are available within the last 6 months, kidney, liver, and heart function should be normal

Must NOT have:

  • Diagnosed actively growing intracranial pathology, such as tumors
  • Misusing illegal substances or alcohol
  • Previous history of stroke
  • History of aggression or violence
  • History of major psychiatric illness
  • No underlying central nervous system pathology

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.


Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Baylor Research Institute

Collaborator Sponsor

  • Quietmind Foundation

Source: ID: NCT03750409